246 related articles for article (PubMed ID: 35671473)
1. Universal Barcoding Predicts
Da Silva Sanchez AJ; Dobrowolski C; Cristian A; Echeverri ES; Zhao K; Hatit MZC; Loughrey D; Paunovska K; Dahlman JE
Nano Lett; 2022 Jun; 22(12):4822-4830. PubMed ID: 35671473
[TBL] [Abstract][Full Text] [Related]
2. The Extent to Which Lipid Nanoparticles Require Apolipoprotein E and Low-Density Lipoprotein Receptor for Delivery Changes with Ionizable Lipid Structure.
Paunovska K; Da Silva Sanchez AJ; Lokugamage MP; Loughrey D; Echeverri ES; Cristian A; Hatit MZC; Santangelo PJ; Zhao K; Dahlman JE
Nano Lett; 2022 Dec; 22(24):10025-10033. PubMed ID: 36521071
[TBL] [Abstract][Full Text] [Related]
3. Lipid Nanoparticle (LNP) Chemistry Can Endow Unique
Johnson LT; Zhang D; Zhou K; Lee SM; Liu S; Dilliard SA; Farbiak L; Chatterjee S; Lin YH; Siegwart DJ
Mol Pharm; 2022 Nov; 19(11):3973-3986. PubMed ID: 36154076
[TBL] [Abstract][Full Text] [Related]
4. siRNA delivery to lymphatic endothelial cells via ApoE-mediated uptake by lipid nanoparticles.
Sakurai Y; Yoshikawa K; Arai K; Kazaoka A; Aoki S; Ito K; Nakai Y; Tange K; Furihata T; Tanaka H; Akita H
J Control Release; 2023 Jan; 353():125-133. PubMed ID: 36414194
[TBL] [Abstract][Full Text] [Related]
5. Lipid nanoparticles containing labile PEG-lipids transfect primary human skin cells more efficiently in the presence of apoE.
Gregersen CH; Mearraoui R; Søgaard PP; Clergeaud G; Petersson K; Urquhart AJ; Simonsen JB
Eur J Pharm Biopharm; 2024 Apr; 197():114219. PubMed ID: 38368913
[TBL] [Abstract][Full Text] [Related]
6. Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver.
Kim M; Jeong M; Hur S; Cho Y; Park J; Jung H; Seo Y; Woo HA; Nam KT; Lee K; Lee H
Sci Adv; 2021 Feb; 7(9):. PubMed ID: 33637537
[TBL] [Abstract][Full Text] [Related]
7. Substituting racemic ionizable lipids with stereopure ionizable lipids can increase mRNA delivery.
Da Silva Sanchez AJ; Zhao K; Huayamares SG; Hatit MZC; Lokugamage MP; Loughrey D; Dobrowolski C; Wang S; Kim H; Paunovska K; Kuzminich Y; Dahlman JE
J Control Release; 2023 Jan; 353():270-277. PubMed ID: 36423872
[TBL] [Abstract][Full Text] [Related]
8. Structure, activity and uptake mechanism of siRNA-lipid nanoparticles with an asymmetric ionizable lipid.
Suzuki Y; Ishihara H
Int J Pharm; 2016 Aug; 510(1):350-8. PubMed ID: 27374199
[TBL] [Abstract][Full Text] [Related]
9. Analyzing 2000 in Vivo Drug Delivery Data Points Reveals Cholesterol Structure Impacts Nanoparticle Delivery.
Paunovska K; Gil CJ; Lokugamage MP; Sago CD; Sato M; Lando GN; Gamboa Castro M; Bryksin AV; Dahlman JE
ACS Nano; 2018 Aug; 12(8):8341-8349. PubMed ID: 30016076
[TBL] [Abstract][Full Text] [Related]
10. The Transcriptional Response to Lung-Targeting Lipid Nanoparticles
Radmand A; Lokugamage MP; Kim H; Dobrowolski C; Zenhausern R; Loughrey D; Huayamares SG; Hatit MZC; Ni H; Del Cid A; Da Silva Sanchez AJ; Paunovska K; Schrader Echeverri E; Shajii A; Peck H; Santangelo PJ; Dahlman JE
Nano Lett; 2023 Feb; 23(3):993-1002. PubMed ID: 36701517
[TBL] [Abstract][Full Text] [Related]
11. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
12. A Direct Comparison of in Vitro and in Vivo Nucleic Acid Delivery Mediated by Hundreds of Nanoparticles Reveals a Weak Correlation.
Paunovska K; Sago CD; Monaco CM; Hudson WH; Castro MG; Rudoltz TG; Kalathoor S; Vanover DA; Santangelo PJ; Ahmed R; Bryksin AV; Dahlman JE
Nano Lett; 2018 Mar; 18(3):2148-2157. PubMed ID: 29489381
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of lipid nanoparticle to lymphatic endothelial cells via anti-podoplanin antibody.
Sakurai Y; Abe N; Yoshikawa K; Oyama R; Ogasawara S; Murata T; Nakai Y; Tange K; Tanaka H; Akita H
J Control Release; 2022 Sep; 349():379-387. PubMed ID: 35787913
[TBL] [Abstract][Full Text] [Related]
14. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.
Zhang R; El-Mayta R; Murdoch TJ; Warzecha CC; Billingsley MM; Shepherd SJ; Gong N; Wang L; Wilson JM; Lee D; Mitchell MJ
Biomater Sci; 2021 Feb; 9(4):1449-1463. PubMed ID: 33404020
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E Binding Drives Structural and Compositional Rearrangement of mRNA-Containing Lipid Nanoparticles.
Sebastiani F; Yanez Arteta M; Lerche M; Porcar L; Lang C; Bragg RA; Elmore CS; Krishnamurthy VR; Russell RA; Darwish T; Pichler H; Waldie S; Moulin M; Haertlein M; Forsyth VT; Lindfors L; Cárdenas M
ACS Nano; 2021 Apr; 15(4):6709-6722. PubMed ID: 33754708
[TBL] [Abstract][Full Text] [Related]
16. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle single-cell multiomic readouts reveal that cell heterogeneity influences lipid nanoparticle-mediated messenger RNA delivery.
Dobrowolski C; Paunovska K; Schrader Echeverri E; Loughrey D; Da Silva Sanchez AJ; Ni H; Hatit MZC; Lokugamage MP; Kuzminich Y; Peck HE; Santangelo PJ; Dahlman JE
Nat Nanotechnol; 2022 Aug; 17(8):871-879. PubMed ID: 35768613
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms.
Akinc A; Querbes W; De S; Qin J; Frank-Kamenetsky M; Jayaprakash KN; Jayaraman M; Rajeev KG; Cantley WL; Dorkin JR; Butler JS; Qin L; Racie T; Sprague A; Fava E; Zeigerer A; Hope MJ; Zerial M; Sah DW; Fitzgerald K; Tracy MA; Manoharan M; Koteliansky V; Fougerolles Ad; Maier MA
Mol Ther; 2010 Jul; 18(7):1357-64. PubMed ID: 20461061
[TBL] [Abstract][Full Text] [Related]
19. An apolipoprotein E modified liposomal nanoparticle: ligand dependent efficiency as a siRNA delivery carrier for mouse-derived brain endothelial cells.
Tamaru M; Akita H; Kajimoto K; Sato Y; Hatakeyama H; Harashima H
Int J Pharm; 2014 Apr; 465(1-2):77-82. PubMed ID: 24530390
[TBL] [Abstract][Full Text] [Related]
20. High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo.
Huayamares SG; Lokugamage MP; Rab R; Da Silva Sanchez AJ; Kim H; Radmand A; Loughrey D; Lian L; Hou Y; Achyut BR; Ehrhardt A; Hong JS; Sago CD; Paunovska K; Echeverri ES; Vanover D; Santangelo PJ; Sorscher EJ; Dahlman JE
J Control Release; 2023 May; 357():394-403. PubMed ID: 37028451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
